Cadence Capital Management’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-307,294
| Closed | -$1.88M | – | 475 |
|
|
2018
Q4 | $1.88M | Buy |
+307,294
| New | +$1.88M | 0.19% | 165 |
|
|
2017
Q4 | – | Sell |
-173,808
| Closed | -$1.07M | – | 683 |
|
|
2017
Q3 | $1.07M | Buy |
173,808
+8,449
| +5% | +$51.8K | 0.07% | 374 |
|
|
2017
Q2 | $1.2M | Buy |
165,359
+33,433
| +25% | +$242K | 0.08% | 312 |
|
|
2017
Q1 | $699K | Buy |
131,926
+23,506
| +22% | +$125K | 0.05% | 438 |
|
|
2016
Q4 | $778K | Buy |
108,420
+2,745
| +3% | +$19.7K | 0.05% | 407 |
|
|
2016
Q3 | $989K | Buy |
+105,675
| New | +$989K | 0.07% | 315 |
|